When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women

被引：0
|
作者：
Seidman, Andrew D. [1 ,2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Weill Cornell Med Coll, New York, NY USA
来源：
ONCOLOGY-NEW YORK | 2016年 / 30卷 / 03期
关键词：
MONOTHERAPY; PALBOCICLIB;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：224 / 228
页数：5
相关论文
共 50 条
  • [41] FulvestrantA Review of its Use in Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women with Disease Progression following Antiestrogen Therapy
    Kate McKeage
    Monique P. Curran
    Greg L. Plosker
    Drugs, 2004, 64 : 633 - 648
  • [42] FULVESTRANT ('FASLODEX'): A NEW OPTION FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE, ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN
    Kleeberg, Ulrich R.
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3537 - 3537
  • [43] New Targets in Endocrine-Resistant Hormone Receptor-Positive Breast Cancer
    Kennedy, Laura C.
    Mayer, Ingrid A.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (08) : 511 - 521
  • [44] Mechanisms of endocrine resistance in hormone receptor-positive breast cancer
    Gao, Yuan
    Yu, Yang
    Zhang, Mingqing
    Yu, Wenjun
    Kang, Lihua
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [45] WinPro: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early-stage hormone receptor-positive breast cancer
    Downton, Teesha
    Segara, Davendra
    Ong, Andrew
    Bingham, Janne
    Carson, Emma-Kate
    Chen, Julia
    Middleton, Kate
    Lindeman, Geoffrey
    Parker, Andrew
    Lim, Elgene
    CANCER RESEARCH, 2023, 83 (05)
  • [46] The WinPro study: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early stage hormone receptor-positive breast cancer
    Carson, E.
    Segara, D.
    Parker, A.
    O'Toole, S.
    Coates, A.
    Mann, B.
    Lindeman, G.
    Tilley, W.
    Lim, E.
    CANCER RESEARCH, 2019, 79 (04)
  • [47] The WinPro study: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early stage hormone receptor-positive breast cancer
    Lim, Elgene
    Carson, Emma
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 194 - 195
  • [48] Overcoming endocrine resistance in hormone receptor-positive breast cancer
    AlFakeeh, A.
    Brezden-Masley, C.
    CURRENT ONCOLOGY, 2018, 25 : S18 - S27
  • [49] Lapatinib in Postmenopausal Women with Hormone Receptor-Positive, HER2-Positive Metastatic Breast CancerProfile Report
    Monique P. Curran
    BioDrugs, 2011, 25 : 53 - 54
  • [50] Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea
    Beom, Seung Hoon
    Oh, Jisu
    Kim, Tae-Yong
    Lee, Kyung-Hun
    Yang, Yaewon
    Suh, Koung Jin
    Moon, Hyeong-Gon
    Han, Sae-Won
    Oh, Do-Youn
    Han, Wonshik
    Kim, Tae-You
    Noh, Dong-Young
    Im, Seock-Ah
    CANCER RESEARCH AND TREATMENT, 2017, 49 (02): : 454 - 463
12345